Oncology

About Synchronicity Pharma

Synchronicity Pharma is a private, preclinical-stage biotech translating foundational circadian biology research into novel therapeutics. Its pipeline targets two distinct areas: microsatellite-stable colorectal cancer (MSS CRC) and sleep disturbances in pediatric autism spectrum disorder (ASD). The company is led by an experienced management team and guided by a world-class scientific advisory board, including luminaries in circadian science like Dr. Steve Kay and Dr. Joseph Takahashi. Its strategy hinges on modulating protein-protein interactions within the circadian clock machinery to address diseases with high unmet need.

Therapeutic Areas